NCT06345469View on ClinicalTrials.gov

Cost Analysis of Therapies for Severe Anemia

Not yet recruitingOBSERVATIONAL

Enrollment

640

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

May 1, 2026

Conditions

Severe Anemia

Interventions

OTHER

Patient blood management (PBM)

PBM means the medical enhancement of the participants own hematopoietic reserve to treat anemia and to reduce the ill effects of disease and bleeding on hematopoiesis and homeostasis.

BIOLOGICAL

Allogeneic transfusion

transfusion of donor red cells

All Listed Sponsors

collaborator

Marisa Eichner

UNKNOWN

lead

Helios Klinik Gotha/Ohrdruf

OTHER

NCT06345469 - Cost Analysis of Therapies for Severe Anemia | Biotech Hunter | Biotech Hunter